• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Pharma
    • Oncology
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Supply Chain
    • AI and Machine Learning
  • Awards
    • Outsourcing Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Pharma
    • Oncology
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Supply Chain
    • AI and Machine Learning
  • Awards
    • Outsourcing Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

Pharma

Magnifying glass with pills on blue
Pharma

Regulatory tracker: AbbVie scores pair of EU nods for Rinvoq

Here, we're tracking the regulatory progress of in-market products, including expansions into key geographies and new indications.
Angus Liu , Kevin Dunleavy , Fraiser Kansteiner Jul 30, 2026 3:15pm
photo of a pair of hands that show the skin condition vitiligo

Pfizer plots Litfulo vitiligo filings, pressuring Incyte, AbbVie

Jul 30, 2026 2:15pm
The CSO Model Is Endangered Heres How Contract Field Organizations Must Evolve to Survive

The CSO Model Is Endangered. Here’s How to Evolve.

Brought to you by Mix Talent
Stock market drop

Alnylam shares tank 29% as Amvuttra disappoints

Jul 30, 2026 11:35am
Top Line Podcast - ZS

Designing an agentic, future‑ready tech roadmap for emerging pharma

Brought to you by ZS
Regeneron

Regeneron revenue up 17% thanks to booming Dupixent sales

Jul 30, 2026 11:26am
Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Biotech
    • Fierce Healthcare
    • Fierce Pharma
  • Our Events
    • Life Sciences Events
©2026 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings